{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-25-000072","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.244412+00:00","generated_at":"2026-05-24T03:43:17.121933+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PacBio appoints Jim Gibson as CFO, effective March 31, 2025","bullets":["Jim Gibson appointed CFO effective March 31, 2025; Christian Henry ceases as interim CFO.","Gibson previously CFO at Sequoia and Willow Innovations; held exec roles at GoDaddy, Tesla, Apple, Netflix.","Compensation: $500k base salary, 55% target bonus, 2M stock options, 1M RSUs with standard vesting.","Severance provides 12 months salary and COBRA; change-in-control triggers full equity acceleration.","PacBio targets positive cash flows by end of 2027, per press release announcing Gibson's hiring."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-25-000072","json":"https://secwatch.observer/filing/0001299130-25-000072.json","markdown":"https://secwatch.observer/filing/0001299130-25-000072.md","text":"https://secwatch.observer/filing/0001299130-25-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/pacb-20250324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:43:17.121933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c2bc876c9","claim":"Jim R. Gibson was appointed as Chief Financial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"On March 24, 2025, Pacific Biosciences of California, Inc. (the “Company”) entered into an offer letter with Jim R. Gibson to serve as its Chief Financial Officer. Mr. Gibson will be appointed as the Company’s Chief Financial Officer and principal financial officer effective as of as his first date of employment, which is anticipated to be March 31, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"806f313017","claim":"Christian Henry changed role as President and Chief Executive Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"Christian Henry, the Company’s President and Chief Executive Officer, who has been serving also as the Company’s interim Chief Financial Officer and principal financial officer since December 6, 2024 will cease serving as interim Chief Financial Officer and principal financial officer upon commencement of Mr. Gibson’s employment but will continue serving as the Company’s President and Chief Executive officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913025000072/0001299130-25-000072-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceases serving as interim CFO"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}